Steeghs, N., Gelderblom, H., Wessels, J., Eskens, F. A. L. M., de Bont, N., Nortier, J. W. R., & Guchelaar, H. (2009). Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors. Springer US.

Steeghs, Neeltje, Hans Gelderblom, Judith Wessels, Ferry A. L. M. Eskens, Natasja de Bont, Johan W. R. Nortier, و Henk-Jan Guchelaar. Pharmacogenetics of Telatinib, a VEGFR-2 and VEGFR-3 Tyrosine Kinase Inhibitor, Used in Patients With Solid Tumors. Springer US, 2009.

Steeghs, Neeltje, et al. Pharmacogenetics of Telatinib, a VEGFR-2 and VEGFR-3 Tyrosine Kinase Inhibitor, Used in Patients With Solid Tumors. Springer US, 2009.